Substance Abuse Billing Experts

Substance Abuse Medical Billing Services

Substance abuse billing operates under a unique framework that includes residential, outpatient, and medication-assisted treatment programs.

Substance Abuse Medical Billing Services
93%

Authorization maintenance rate

30%

Revenue improvement average

60%

Reduction in retroactive denials

22 days

Average days to payment

Overview

Revenue Cycle Solutions for Addiction Treatment Facilities

Substance abuse billing operates under a unique framework that includes residential, outpatient, and medication-assisted treatment programs. HCPCS codes for methadone administration (H0020), buprenorphine management, and naltrexone injections (J2315) each follow different billing pathways depending on the treatment setting and payer. Medicaid expansion has increased coverage for substance use disorder treatment, but each state's managed care organization applies its own prior authorization and billing rules.

Intensive outpatient program (IOP) billing uses per-session or per-diem codes that vary by payer. Group therapy (90853), individual counseling (H0004), and case management (H0006) performed during the same program day must be documented separately with distinct clinical content. Payers audit substance abuse claims for medical necessity at higher rates than most other behavioral health services.

Revenue Cycle Solutions for Addiction Treatment Facilities
Challenges

Common Substance Abuse billing Challenges We Solve

Every Substance Abuse billing team deals with payer delays, coding nuance, and collection leakage. We tighten those weak points before they turn into write-offs.

Multi-Level Care Billing Transitions

Patients move between detox, residential, PHP, IOP, and outpatient levels during a single treatment episode. Billing each transition correctly with proper discharge and admission coding prevents revenue gaps between care levels.

Authorization and Length-of-Stay Reviews

Payers conduct concurrent utilization reviews every 3-7 days for residential and inpatient treatment. Submitting clinical updates that meet ASAM criteria for continued stay is essential to maintaining authorization and avoiding retroactive denials.

MAT Medication Reimbursement

Medication-assisted treatment billing requires coordinating drug product codes (J-codes), administration fees, and the associated counseling services. Reimbursement rates vary widely between commercial, Medicaid, and SAMHSA grant-funded programs.

Drug Testing Compliance and Coding

Drug testing codes (80305-80307 presumptive, 80320-80377 definitive) face heavy payer scrutiny. Billing excessive testing frequency or unsupported definitive testing triggers audits and recoupment demands.

Services

Complete Substance Abuse billing Services

Support spans the full revenue cycle, from front-end verification to denial recovery and reporting.

Multi-level addiction treatment billing

Medication-assisted treatment (MAT) coding

Utilization review and authorization management

Drug testing coding and compliance monitoring

Medicaid behavioral health carve-out billing

SBIRT screening and brief intervention coding

Coverage

Serving Substance Abuse billing Teams Nationwide

We support independent practices, multisite groups, and growing provider organizations with flexible workflows.

Independent physician groups

Multi-location practices

Private equity backed platforms

Hospital-owned outpatient groups

Guide

The Complete Guide to Substance Abuse billing

Substance Abuse Medical Billing Overview

A small clinic in rural Ohio started seeing more patients than ever in 2023. Their counselors were booked weeks out, their group therapy rooms were full every evening, and their intake coordinator was fielding calls around the clock. But their collections rate sat at 61%. Claims were going out, denials were coming back, and nobody on staff had time to figure out why. The problem was not the care. It was the billing.

Substance abuse and addiction treatment billing operates under a set of rules that catches many practices off guard. The Mental Health Parity and Addiction Equity Act (MHPAEA) requires insurers like UnitedHealthcare, Aetna, and Cigna to cover substance use disorder (SUD) treatment at parity with medical and surgical benefits, but enforcement is inconsistent. Medicaid covers a broad range of SUD services in most states, yet prior authorization requirements vary widely. Medicare covers certain outpatient SUD counseling and medication-assisted treatment (MAT), but only under specific provider enrollment criteria. Getting paid requires knowing these rules cold.

Common Billing Challenges in Substance Abuse

  • Medical necessity documentation gaps: Payers including BCBS and Humana deny SUD claims frequently because clinical notes do not clearly establish medical necessity. Counselors document care for their patients, not for payers. That gap costs practices tens of thousands in denied claims each year.
  • H-code vs. CPT code confusion: SUD billing uses a hybrid of HCPCS H-codes (H0001 for alcohol and drug assessment, H0015 for intensive outpatient treatment) and standard CPT codes. Mixing them incorrectly, or billing H-codes to payers that require CPT, triggers automatic denials.
  • Level of care mismatches: ASAM criteria define the appropriate level of care, from Level 1 outpatient to Level 3.5 residential. Billing the wrong level, or failing to document why a patient needs a higher level, leads to downcoding or outright denial by payers like Cigna and UnitedHealthcare.
  • Credentialing and provider type issues: Payers often restrict which provider types can bill for SUD services. Licensed counselors (LPCs), licensed clinical social workers (LCSWs), and certified addiction specialists may not be paneled correctly, causing claims to deny as non-covered even when the service itself is covered.

Key CPT Codes for Substance Abuse Billing

  • H0001: Alcohol and drug assessment, used for initial evaluations with payers accepting HCPCS H-codes
  • H0015: Intensive outpatient treatment, typically billed per diem for IOP programs (three or more hours per day)
  • 90832: Individual psychotherapy, 30 minutes, commonly used for counseling sessions in outpatient SUD settings
  • 90834: Individual psychotherapy, 45 minutes, the standard billing unit for most counseling sessions with major commercial payers
  • 90853: Group psychotherapy, billed per patient per session for group therapy programs
  • 99213 / 99214: Office or outpatient evaluation and management codes used when a physician or mid-level provider manages MAT medications such as buprenorphine

Revenue Cycle Considerations for Substance Abuse

SUD practices typically see denial rates between 18% and 28%, well above the 10-15% benchmark for general medical practices. The main culprits are authorization failures, missing ASAM documentation, and provider credentialing errors. Average days in accounts receivable for SUD providers runs 45 to 60 days, compared to 30 to 40 days for primary care. Cash flow problems compound quickly when your highest-volume payer, often Medicaid, takes 30 days to process and frequently requires resubmission.

Payer mix matters enormously in this specialty. Medicaid often makes up 40% to 60% of the payer mix for community-based SUD providers. That creates vulnerability: any Medicaid policy change, fee schedule update, or prior authorization requirement shift hits revenue hard. Commercial payers like BCBS and Aetna typically reimburse 20% to 35% higher than Medicaid for the same services, making credentialing with commercial plans a priority for revenue optimization.

How My Medical Bill Solution Helps Substance Abuse Practices

My Medical Bill Solution works with SUD providers who are tired of watching denied claims pile up while their clinical staff handles billing questions they were never trained to answer. We handle the full revenue cycle: insurance verification and eligibility checks before each patient starts treatment, prior authorization management for IOP and residential levels of care, accurate coding using both CPT and H-code sets, and aggressive denial follow-up with payer-specific appeal letters.

We also support MAT programs billing buprenorphine management visits under 99213 and 99214, and we understand the documentation requirements that Cigna, Humana, and UnitedHealthcare use to evaluate medical necessity for SUD claims. We track MHPAEA parity compliance across all commercial plans and pursue corrective action when payers apply stricter limits to SUD services than they apply to comparable medical benefits. The Ohio clinic from our opening story reduced their denial rate from 28% to 9% in four months. Their collections rate climbed to 89%. That kind of result does not happen by accident. It happens when billing specialists who know this specialty handle the work. Contact My Medical Bill Solution today to see what your practice is actually leaving on the table.

Common Questions

Frequently Asked Questions About Substance Abuse billing

Answers to the questions practice owners and managers ask most often before switching billing partners.

How do you handle billing for residential treatment programs?

We bill residential treatment using per-diem codes (H0018 short-term, H0019 long-term) with proper room-and-board separation from clinical services. We manage concurrent review submissions to maintain authorization throughout the stay and bill ancillary services (individual therapy, group sessions, medical evaluations) as separately reimbursable when the per-diem rate does not include them.

How do you manage MAT billing across different payers?

We code buprenorphine induction and maintenance (H0033 with appropriate J-codes), injectable naltrexone (J2315), and methadone maintenance (H0020) using payer-specific billing rules. For commercial plans, we verify formulary coverage. For Medicaid, we follow state-specific MAT billing guidelines. For SAMHSA-funded programs, we coordinate grant billing with insurance claims.

What is your approach to drug testing billing compliance?

We follow evidence-based testing frequency guidelines, bill presumptive screening (80305-80307) at clinically appropriate intervals, and submit definitive testing (80320-80377) only when the clinical record supports the need for specific substance confirmation. This approach keeps testing revenue flowing while avoiding the audit triggers that excessive testing creates.

Do you handle Medicaid managed behavioral health billing?

Yes. We navigate state-specific Medicaid behavioral health carve-out arrangements, submit claims to the correct managed behavioral health organization, and manage the different authorization and coding requirements that Medicaid managed care plans impose compared to commercial insurance.

How do you bill for intensive outpatient programs (IOP)?

We bill IOP services using H0015 per session or per diem based on payer requirements, ensure the minimum 9-hour weekly service threshold is documented, and separately code individual sessions, family therapy, and medication management when they fall outside the IOP bundled rate.

What financial improvements do addiction treatment facilities see?

Our substance abuse treatment clients see revenue increases of 20-30%, primarily from capturing previously unbilled ancillary services, maintaining authorization throughout residential stays (reducing retroactive denials by 60%), and optimizing MAT billing across mixed payer populations.

Comparison

How We Compare for Substance Abuse billing

The difference is operational discipline. We focus on clean submissions, fast follow-up, and transparency.

Criteria My Medical Bill Solution Typical Provider
Specialty-specific billing workflows Included Often generic
Dedicated account ownership Yes Shared queue
Denial root-cause reporting Weekly Ad hoc
Claim submission speed Within 24 hours Varies
Communication cadence Planned check-ins Reactive only

Start Billing Smarter for Substance Abuse billing

Get a revenue review and a clear action plan tailored to your practice, payers, and claim mix.